Skip to main content

Important Notification: Extension of time-lines by Indian patent office in view of extended lockdown

As you are aware, India was in a complete lockdown from 25th March 2020 to 3rd May, 2020 (lockdowns 1 and 2) and Indian patent Office was closed until 3rd May 2020. In order to curtail the spread of COVID-19, the Indian Government on 1st May, 2020 decided to extend the nation-wide lockdown (lockdown-3) until 17th May 2020.

Indian Patent Office (IPO) by the order of Ministry of Home Affairs dated 15th April, 2020, started functioning from 20th April, 2020 with full staff of the rank of Deputy Controller and above and one-third staff strength up to the rank of Assistant Controller on all workings days.

In view of the recent lockdown-3, IPO has issued a notification on 4th May 2020, according to which all deadlines and timelines prescribed under the IP Acts and Rules that fall due during the period of lockdown will automatically get extended to the date on lockdown -3 ends i.e. 18th May, 2020.

Even though the deadlines have been extended and India remains locked down until 18th May 2020, we are pleased to inform you that our team is working remotely at almost full capacity.

Be safe, Stay safe!

 

Most Recent

News & Insights

VIEW ALL
News & Updates, Thought Leadership
•
Oct 27, 2026

When a pharmaceutical company develops a new formulation of an existing drug, is it creating a genuine innovation or extending its monopoly over a medicine

Evergreening or Genuine Innovation? The Patentability of New Drug Formulations in India
News & Updates, Thought Leadership
•
Oct 23, 2026

Imagine a researcher using artificial intelligence to identify a new material, a pharmaceutical team using machine learning to discover a promising compound,

Can AI-Assisted Inventions Be Patented in India?
News & Updates, Thought Leadership
•
Oct 20, 2026

Every time someone publishes an article, uploads a photograph, releases a song or shares research online, they contribute to an expanding body of human

Who Owns Internet’s Knowledge? Copyright, AI Training and Indian Law
News & Updates, Thought Leadership
•
Oct 17, 2026

An active pharmaceutical ingredient (API) is the substance responsible for a medicine’s therapeutic effect. Developing one can involve years of chemical

API Process Patents in India: Key Patent Infringement Disputes and Court Decisions